Search
ASGCT 2026: Dispatch Bio is trying to solve the solid tumor challenge for CAR-T by designing bespoke antigens that light up tumors. At ASGCT, they also have data on a unique cytokine for armoring CARs
Co-Founder Lex Johnson walks us through the science, which is nearing the clinic with partner Bristol. Plus, an explanation of the ASGCT presentation on their cytokine and why they believe it is important. Coverage brought to you by
May 13
.png){kind=logo}